Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 135

Similar articles for PubMed (Select 23441447)

1.

[Silencing pyruvate kinase M2 sensitizes human prostate cancer PC3 cells to gambogic acid-induced apoptosis].

Lü L, Wang L, Jiang GS, Zhang CH, Zeng FQ.

Zhonghua Nan Ke Xue. 2013 Feb;19(2):102-6. Chinese.

PMID:
23441447
2.

[MiR-124 suppresses the proliferation of human prostate cancer PC3 cells by targeting PKM2].

Lü L, Yuan JD, Cao ZL, Huang T, Zhang CH, Wang L, Zeng FQ.

Zhonghua Nan Ke Xue. 2014 Jun;20(6):495-9. Chinese.

PMID:
25029852
4.

Suppression of IGHG1 gene expression by siRNA leads to growth inhibition and apoptosis induction in human prostate cancer cell.

Pan B, Zheng S, Liu C, Xu Y.

Mol Biol Rep. 2013 Jan;40(1):27-33. doi: 10.1007/s11033-012-1944-x. Epub 2012 Nov 2.

PMID:
23117283
5.

Pyruvate kinase M2 regulates apoptosis of intestinal epithelial cells in Crohn's disease.

Tang Q, Ji Q, Xia W, Li L, Bai J, Ni R, Qin Y.

Dig Dis Sci. 2015 Feb;60(2):393-404. doi: 10.1007/s10620-014-3189-0. Epub 2014 May 11.

PMID:
24817408
6.

Gambogic acid inhibits TNF-α-induced invasion of human prostate cancer PC3 cells in vitro through PI3K/Akt and NF-κB signaling pathways.

Lü L, Tang D, Wang L, Huang LQ, Jiang GS, Xiao XY, Zeng FQ.

Acta Pharmacol Sin. 2012 Apr;33(4):531-41. doi: 10.1038/aps.2011.180. Epub 2012 Mar 19.

7.

Downregulation of Id1 by small interfering RNA in prostate cancer PC3 cells in vivo and in vitro.

Ling YX, Tao J, Fang SF, Hui Z, Fang QR.

Eur J Cancer Prev. 2011 Jan;20(1):9-17. doi: 10.1097/CEJ.0b013e32833ebaa0.

PMID:
20881502
8.

Changes in PKM2 associate with prostate cancer progression.

Wong N, Yan J, Ojo D, De Melo J, Cutz JC, Tang D.

Cancer Invest. 2014 Aug;32(7):330-8. doi: 10.3109/07357907.2014.919306. Epub 2014 Jun 2.

PMID:
24884829
9.

Depletion of PKM2 leads to impaired glycolysis and cell death in 2-demethoxy-2,3-ethylenediamino hypocrellin B-photoinduced A549 cells.

Zhou Z, Liu Y, Qin M, Sheng W, Wang X, Li Z, Zhong R.

J Photochem Photobiol B. 2014 May 5;134:1-8. doi: 10.1016/j.jphotobiol.2014.03.014. Epub 2014 Apr 2.

PMID:
24792468
10.

[Downregulation of PAR expression induces the apoptosis of human prostate cancer PC3 cells and increases the Bcl-2/Bax ratio].

Xu XF, Zhou XM, Wei ZF, Zhang ZY, Ge JP, Wei W, Zhou WQ, Cheng W, Hou JQ, Gao JP.

Zhonghua Nan Ke Xue. 2012 Oct;18(10):896-9. Chinese.

PMID:
23297497
11.

Effect of small interfering RNA targeting hypoxia-inducible factor-1α on radiosensitivity of PC3 cell line.

Huang Y, Yu J, Yan C, Hou J, Pu J, Zhang G, Fu Z, Wang X.

Urology. 2012 Mar;79(3):744.e17-24. doi: 10.1016/j.urology.2011.10.024. Epub 2011 Dec 22.

PMID:
22196409
13.

[Inhibitory effect of siRNA targeting ADAM17 on the proliferation of prostate cancer PC-3 cells].

Lin F, Lin P, Liu X, Li D, Liu ZJ, Zou HF, Jiang Y, Zhao XF, Feng JL, Yu XG.

Zhonghua Nan Ke Xue. 2012 Aug;18(8):687-91. Chinese.

PMID:
22934512
14.
15.

Down-regulation of signal transducer and activator of transcription 3 expression using vector-based small interfering RNAs suppresses growth of human prostate tumor in vivo.

Gao L, Zhang L, Hu J, Li F, Shao Y, Zhao D, Kalvakolanu DV, Kopecko DJ, Zhao X, Xu DQ.

Clin Cancer Res. 2005 Sep 1;11(17):6333-41.

16.

Small interfering RNA targeting HMGN5 induces apoptosis via modulation of a mitochondrial pathway and Bcl-2 family proteins in prostate cancer cells.

Zhang XY, Guo ZQ, Ji SQ, Zhang M, Jiang N, Li XS, Zhou LQ.

Asian J Androl. 2012 May;14(3):487-92. doi: 10.1038/aja.2012.18. Epub 2012 Apr 16.

17.

Colon cancer cells maintain low levels of pyruvate to avoid cell death caused by inhibition of HDAC1/HDAC3.

Thangaraju M, Carswell KN, Prasad PD, Ganapathy V.

Biochem J. 2009 Jan 1;417(1):379-89. doi: 10.1042/BJ20081132.

PMID:
18789002
18.
19.

Down-regulation of Egr-1 by siRNA inhibits growth of human prostate carcinoma cell line PC-3.

Parra E, Ortega A, Saenz L.

Oncol Rep. 2009 Dec;22(6):1513-8.

PMID:
19885607
20.

MicroRNA-124 inhibits cancer cell growth through PTB1/PKM1/PKM2 feedback cascade in colorectal cancer.

Taniguchi K, Sugito N, Kumazaki M, Shinohara H, Yamada N, Nakagawa Y, Ito Y, Otsuki Y, Uno B, Uchiyama K, Akao Y.

Cancer Lett. 2015 Jul 10;363(1):17-27. doi: 10.1016/j.canlet.2015.03.026. Epub 2015 Mar 24.

PMID:
25818238
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk